Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

Triptorelin

Decapeptyl, Trelstar, Gonapeptyl, Pamorelin

A synthetic GnRH agonist decapeptide that suppresses gonadotropin and sex hormone production for treating prostate cancer, endometriosis, and precocious puberty.

Quick Stats
Studies 178
Trials 100
Formula C64H82N18O13
Clear All
Utility 3
pubmed Mar 8, 2022

Long-Term Outcomes With Pharmacological Ovarian Suppression During Chemotherapy in Premenopausal Early Breast Cancer Patients.

Lambertini. Matteo M; Boni. Luca L; Michelotti. Andrea A; Magnolfi. Emanuela E; Cogoni. Alessio Alig...

A big Italian study followed women with early breast cancer for over 12 years and found that giving the hormone blocker triptorelin during chemotherapy didn’t change cancer survival but helped protect the ovaries, with a slightly higher chance of getting pregnant later.

Utility 3
pubmed Feb 24, 2022

Efficacy of Pulsatile Gonadotropin-Releasing Hormone Therapy in Male Patients: Comparison between Pituitary Stalk Interruption Syndrome and Congenital Hypogonadotropic Hypogonadism.

Huang. Qibin Q; Mao. Jiangfeng J; Wang. Xi X; Yu. Bingqing B; Ma. Wanlu W; Ji. Wen W; Zhu. Yiyi Y; Z...

Pulsatile GnRH (triptorelin) given continuously can kick‑start sperm production in men with two rare conditions that cause low testosterone. It works in both groups, but men with pituitary stalk interruption need higher doses and have a slightly lower success rate than those with congenital hypogonadotropic hypogonadism.

Utility 3
pubmed Oct 16, 2023

Effects of Deslorelin on Testosterone Secretion and Testicular Volume in Male Rhesus Macaques (<i>Macaca mulatta</i>).

Tran. Helena D HD; Carroll. Kelsey E KE; Mackiewicz. Alexis L AL; Ardeshir. Amir A; Stockinger. Dian...

In a small study with four male rhesus monkeys, a single sub‑cutaneous implant of the GnRH‑agonist deslorelin lowered testosterone and shrank testicles, but the time it took to work and how long the effect lasted varied a lot between animals.

Utility 3
pubmed May 8, 2023

Incidence and severity of ovarian hyperstimulation syndrome (OHSS) in high responders after gonadotropin-releasing hormone (GnRH) agonist trigger in "freeze-all" approach.

Fern&#xe1;ndez-S&#xe1;nchez. M M; Fatemi. H H; Garc&#xed;a-Velasco. J A JA; Heiser. P W PW; Daftary....

In women who produce a lot of eggs during IVF, using a GnRH‑agonist shot (triptorelin) to finish egg growth caused mild ovarian hyperstimulation syndrome (OHSS) in about one‑fifth of cases, but no severe cases were seen. The symptoms lasted up to three weeks and were usually managed with cabergoline, a medication that helps prevent the condition from getting worse.

Utility 3
pubmed Nov 17, 2022

Real-world prescription patterns for reproductive assistance patients in China: A trend analysis from 2016 to 2020.

Jin. Jing J; Zhu. Jialei J; Tang. Jing J

The study looked at prescription data from 2016‑2020 for Chinese fertility clinics and found that triptorelin, a hormone used in IVF cycles, is one of the most common and pricey drugs prescribed, especially in big cities like Guangzhou and Shanghai. It shows how often it’s used, typical doses, and how its cost compares to other meds, giving a real‑world picture of IVF drug use in China.

Utility 3
pubmed Jul 30, 2022

Ovulation triggering with hCG alone, GnRH agonist alone or in combination? A randomized controlled trial in advanced-age women undergoing IVF/ICSI cycles.

Zhou. Chengliang C; Yang. Xinyue X; Wang. Yong Y; Xi. Ji J; Pan. Hong H; Wang. Min M; Zhou. Yuzhong...

In women 35 years or older doing IVF, giving both a GnRH‑agonist shot (0.2 mg triptorelin) and a smaller hCG dose (2000 IU) at ovulation time didn’t change how many eggs were collected, but it did produce more high‑quality embryos and higher live‑birth rates compared with using the GnRH‑agonist alone. The results were similar to using hCG alone, so the combo or hCG alone are better choices than the GnRH‑agonist only.

Utility 3
pubmed Sep 9, 2021

Estrogen Replacement Therapy Induces Antioxidant and Longevity-Related Genes in Women after Medically Induced Menopause.

Borr&#xe1;s. C C; Ferrando. M M; Ingl&#xe9;s. M M; Gambini. J J; Lopez-Grueso. R R; Edo. R R; Mas-Ba...

The study shows that when women’s natural hormones are temporarily shut down (like with a GnRH drug such as triptorelin), their blood cells lose important antioxidant and longevity‑related gene activity. Giving back estrogen (and later progesterone) restores those genes and raises the body’s main antioxidant, glutathione, suggesting hormone replacement can boost cellular defenses against aging.

Utility 3
pubmed Nov 15, 2021

Goserelin Ovarian Ablation Failure in Premenopausal Women With Breast Cancer.

Gupta. Aanchal A; Bandaru. Sindhura S; Manthri. Sukesh S

A 36‑year‑old woman with hormone‑sensitive breast cancer was given the GnRH‑agonist goserelin to shut down her ovaries, but after about a year and a half the drug stopped working and her ovaries started making estrogen again. This shows that long‑term use of drugs like goserelin (and similar peptides such as triptorelin) can sometimes lead to resistance, meaning they may not keep hormone levels low forever.

Utility 3
pubmed Dec 2, 2022

Final adult height in children with central precocious puberty - a retrospective study.

Knific. Taja T; Lazarevi&#x10d;. Melisa M; &#x17d;ibert. Janez J; Obolnar. Nika N; Aleksovska. Nata&...

The study looked at using triptorelin, a hormone blocker, in kids with early puberty to see if it helps them grow taller. It found that while treated girls gained about 7 cm more than untreated ones, their final adult heights ended up almost the same because doctors chose who to treat. The drug effectively lowered hormone levels in most kids, but bone age still sped up in some, and many factors (like bone age, BMI, and when treatment starts and stops) influence the final height outcome.

Utility 3
pubmed Nov 12, 2021

Vasculitis-like Palpable Purpuric Rash Induced by Decapeptyl in a Pediatric Patient Diagnosed Central Precocious Puberty.

Galip. Nil&#xfc;fer N; Ankay. Nermin N; Bundak. R&#xfc;veyde R

A 7‑year‑old girl treated with the GnRH‑analog triptorelin (Decapeptyl) for early puberty developed a sudden, widespread rash and fever about eight hours after her second injection, which was diagnosed as drug‑induced vasculitis. The reaction cleared after a short course of steroids and antihistamine, and she was able to continue puberty treatment safely by switching to a different GnRH‑analog, leuprolide.

Utility 3
pubmed Jul 31, 2022

Effect of Implantation and Fixation of Mirena in the Treatment of Adenomyosis and its Influence on Serum Inflammatory Factors.

Leilei. Gong G; Di. Xin X; Na. Li L; Rong. Shao S

A study of 100 women with adenomyosis compared a hormone‑releasing IUD (Mirena) placed during surgery to standard post‑op injections of the peptide drug triptorelin. The IUD group had lower estrogen, less pain, smaller uterine size, lower inflammation, better quality of life, fewer side‑effects and no recurrences, while the triptorelin group showed higher rates of pain, inflammation and recurrence.

Utility 3
pubmed Dec 27, 2021

The impact of androgen deprivation therapy on bone mineral density in men treated for paraphilic disorder: A retrospective cohort study.

De Landtsheer. Ana&#xef;s A; Bekaert. Lieslinde L; David. Karel K; Marcq. Philippe P; Jeandarme. Ing...

Men who take androgen‑blocking drugs like the GnRH agonist triptorelin (often used to lower testosterone) lose bone density over several years. In this study, bone loss was about half a standard deviation at the spine and hip after roughly six years of treatment. People who also took bisphosphonate medicines did not see the same drop, suggesting those drugs can help protect bone.

Utility 2
pubmed May 2, 2024

Risk factors for poor oocyte yield and oocyte immaturity after GnRH agonist triggering.

Gambini. S S; Sonigo. C C; Robin. G G; Cedrin-Durnerin. I I; Vinolas. C C; Sifer. C C; Boumerdassi....

This study looked at why some women get fewer or less mature eggs after using a GnRH‑agonist (triptorelin) to trigger ovulation. It found that women with a low ovarian reserve or low LH levels 12 hours after the trigger tend to retrieve fewer eggs, while higher body weight and higher AMH levels are linked to more immature eggs. Using an antigonadotrophic pretreatment can lower the chance of immature eggs.

Utility 2
pubmed Oct 23, 2025

Efficacy of Huayu Xiaozheng decoction combined with triptorelin and mifepristone in the treatment of uterine fibroids and its effect on uterine artery hemodynamics.

Zhou. Yuru Y; Liu. Xinyuan X; Yang. Xiaotian X; Yu. Yaxin Y; Zhou. Yue Y; Zhou. Huifang H

Adding the Chinese herbal mix Huayu Xiaozheng decoction to the standard drugs triptorelin and mifepristone helped women with uterine fibroids shrink their tumors a bit more, improve blood flow in the uterus, and experience fewer side‑effects, though the drop in fibroid comeback after a year wasn’t statistically clear.

Utility 2
pubmed Jan 10, 2024

Testosterone nadir and clinical outcomes in patients with advanced prostate cancer: Post hoc analysis of triptorelin pamoate Phase III studies.

Klotz. Laurence L; Tat. Tri T

In men with advanced prostate cancer, using the drug triptorelin to lower testosterone to very low levels (<0.35 nmol/L) was linked to longer overall survival, and possibly better cancer‑specific survival, compared to higher testosterone levels. The study shows deeper hormone suppression may improve outcomes in this disease, but the drug is prescription‑only and has significant side‑effects, so it isn’t a simple DIY anti‑aging tool for healthy people.

Utility 2
pubmed Apr 24, 2024

Cost-Effectiveness Analysis of Triptorelin, Goserelin, and Leuprolide in the Treatment of Patients With Metastatic Prostate Cancer: A Societal Perspective.

Rezaee. Mehdi M; Karimzadeh. Iman I; Hashemi-Meshkini. Amir A; Zeighami. Shahryar S; Bazyar. Mohamma...

A study in Iran looked at the long‑term cost and health benefits of three injectable hormones (triptorelin, goserelin, leuprolide) used to treat advanced prostate cancer. Over 20 years, goserelin cost about $13,500 and gave 6.37 quality‑adjusted life years, making it the cheapest and most cost‑effective option compared with the other two drugs.

Utility 2
pubmed Jan 5, 2025

The Impact of Triptorelin on Hormone Levels in Human and Its Metabolite Confirmation Using Liquid Chromatography-Ion Trap/Time-of-Flight Mass Spectrometry (LC/MS-IT-TOF) and Liquid Chromatography-Orbitrap (LC-Orbitrap) for Doping Control Analysis.

Saardpun. Navaporn N; Asawesna. Cholsittapan C; Kaewklam. Seksun S; Sangkhum. Premsant P; Kongchareo...

The study shows that the drug triptorelin, used for prostate cancer, strongly lowers LH and testosterone levels, more so than a similar drug, leuprorelin, and that a specific breakdown product shows up in urine and can be used to catch doping. While it confirms how powerful the hormone blocker is, the drug is prescription‑only and meant for serious medical conditions, so it isn’t a practical supplement for most self‑experimenters.

Utility 2
pubmed Jul 12, 2024

Risk of cardiovascular events following intermittent and continuous androgen deprivation therapy in patients with nonmetastatic prostate cancer.

Preston. Mark A MA; Ebrahimi. Ramin R; Hong. Agnes A; Bobbili. Priyanka P; Desai. Raj R; Duh. Mei Sh...

In men with early-stage prostate cancer, staying on a steady dose of hormone‑blocking drugs (continuous ADT) lowered the chance of serious heart problems compared to taking breaks (intermittent ADT), while the risk of diabetes, cholesterol spikes, or bone loss stayed the same.